SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-24-020779
Filing Date
2024-06-20
Accepted
2024-06-20 16:06:40
Documents
14
Period of Report
2024-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A vxrt20240619_8ka.htm   iXBRL 8-K/A 30125
  Complete submission text file 0001437749-24-020779.txt   165683

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240611.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240611_def.xml EX-101.DEF 11792
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240611_lab.xml EX-101.LAB 15821
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240611_pre.xml EX-101.PRE 12007
17 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240619_8ka_htm.xml XML 3004
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35285 | Film No.: 241056236
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)